Fortress Biotech, Inc. Earnings Per Share (Diluted)
Fortress Biotech, Inc. (FBIO) reported Earnings Per Share (Diluted) of -$0.08 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2026-08-13
- Fortress Biotech, Inc. earnings per share, diluted for the quarter ending 2026-06-30 was -$0.08, a 117.78% decline year-over-year.
- Fortress Biotech, Inc. earnings per share, diluted for the quarter ending 2026-03-31 was $2.82.
- Fortress Biotech, Inc. earnings per share, diluted for the quarter ending 2025-12-31 was $1.34, a 41.93% decline year-over-year.
- Fortress Biotech, Inc. earnings per share, diluted for the quarter ending 2025-09-30 was $0.11.
- Fortress Biotech, Inc. earnings per share, diluted for fiscal 2025 was -$0.07.
- Fortress Biotech, Inc. earnings per share, diluted for fiscal 2024 was -$2.69.
- Fortress Biotech, Inc. earnings per share, diluted for fiscal 2023 was -$8.47.
- Fortress Biotech, Inc. earnings per share, diluted for fiscal 2022 was -$15.97.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 3 month as first filed | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 6 month as first filed | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 9 month as first filed | Earnings Per Share, Diluted 12 month | Earnings Per Share, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$0.08 10-Q · filed 2026-08-13 | $2.86 10-Q · filed 2026-08-13 | $4.55 derived: net income ÷ weighted average shares · filed 2026-08-13 | $4.62 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2026-03-31 | $2.82 10-Q · filed 2026-05-14 | $4.72 derived: net income ÷ weighted average shares · filed 2026-05-14 | $4.70 derived: net income ÷ weighted average shares · filed 2026-05-14 | $5.23 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-12-31 | $1.34 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.22 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.73 derived: net income ÷ weighted average shares · filed 2026-08-13 | -$0.07 10-K · filed 2026-03-31 | ||||
| 2025-09-30 | $0.11 10-Q · filed 2025-11-14 | $0.68 derived: net income ÷ weighted average shares · filed 2026-08-13 | $0.14 10-Q · filed 2025-11-14 | $2.46 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-06-30 | $0.45 10-Q · filed 2026-08-13 | $0.02 10-Q · filed 2026-08-13 | $2.37 derived: net income ÷ weighted average shares · filed 2026-08-13 | $2.05 derived: net income ÷ weighted average shares · filed 2026-08-13 | ||||
| 2025-03-31 | -$0.48 10-Q · filed 2026-05-14 | $1.89 derived: net income ÷ weighted average shares · filed 2026-05-14 | $1.53 derived: net income ÷ weighted average shares · filed 2026-05-14 | $1.14 derived: net income ÷ weighted average shares · filed 2026-05-14 | ||||
| 2024-12-31 | $2.32 derived: net income ÷ weighted average shares · filed 2026-04-28 | $2.07 derived: net income ÷ weighted average shares · filed 2026-04-28 | $1.71 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$2.69 10-K · filed 2026-03-31 | ||||
| 2024-09-30 | -$0.76 10-Q · filed 2025-11-14 | -$1.25 derived: net income ÷ weighted average shares · filed 2025-11-14 | -$2.43 10-Q · filed 2025-11-14 | $2.62 derived: net income ÷ weighted average shares · filed 2026-04-28 | ||||
| 2024-06-30 | -$0.73 10-Q · filed 2025-08-14 | -$1.76 10-Q · filed 2025-08-14 | $3.63 derived: net income ÷ weighted average shares · filed 2026-04-28 | $3.79 derived: net income ÷ weighted average shares · filed 2026-04-28 | ||||
| 2024-03-31 | -$1.04 10-Q · filed 2025-05-15 | $4.80 derived: net income ÷ weighted average shares · filed 2026-04-28 | $5.25 derived: net income ÷ weighted average shares · filed 2026-04-28 | $3.47 derived: net income ÷ weighted average shares · filed 2026-04-28 | ||||
| 2023-12-31 | $7.66 derived: net income ÷ weighted average shares · filed 2026-04-28 | $8.47 derived: net income ÷ weighted average shares · filed 2026-04-28 | $6.15 derived: net income ÷ weighted average shares · filed 2026-04-28 | -$8.47 10-K · filed 2025-03-31 | ||||
| 2023-09-30 | -$0.94 10-Q · filed 2024-11-14 | -$4.01 derived: net income ÷ weighted average shares · filed 2024-11-14 | -$7.94 10-Q · filed 2024-11-14 | -$2.55 derived: net income ÷ weighted average shares · filed 2024-11-14 | ||||
| 2023-06-30 | -$3.65 10-Q · filed 2024-08-13 | -$0.24 10-Q · filed 2023-08-14 | -$7.14 10-Q · filed 2024-08-13 | -$0.47 10-Q · filed 2023-08-14 | -$1.91 derived: net income ÷ weighted average shares · filed 2024-08-13 | -$3.16 derived: net income ÷ weighted average shares · filed 2024-08-13 | ||
| 2023-03-31 | -$0.21 10-Q · filed 2023-05-15 | -$0.90 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.87 derived: net income ÷ weighted average shares · filed 2024-05-15 | -$1.82 derived: net income ÷ weighted average shares · filed 2024-05-15 | ||||
| 2022-12-31 | -$4.46 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$8.24 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$2.11 derived: net income ÷ weighted average shares · filed 2024-03-28 | -$15.97 10-K · filed 2024-03-28 | -$0.97 10-K · filed 2023-03-31 | |||
| 2022-09-30 | -$4.11 10-Q · filed 2023-11-14 | -$0.25 10-Q · filed 2022-11-14 | -$0.93 derived: net income ÷ weighted average shares · filed 2023-11-14 | -$11.15 10-Q · filed 2023-11-14 | -$0.68 10-Q · filed 2022-11-14 | -$1.38 derived: net income ÷ weighted average shares · filed 2023-11-14 | ||
| 2022-06-30 | -$0.26 10-Q · filed 2023-08-14 | -$0.24 10-Q · filed 2022-08-11 | -$0.47 10-Q · filed 2023-08-14 | -$0.42 10-Q · filed 2022-08-11 | -$0.80 derived: net income ÷ weighted average shares · filed 2023-08-14 | -$1.05 derived: net income ÷ weighted average shares · filed 2023-08-14 | ||
| 2022-03-31 | -$0.18 10-Q · filed 2023-05-15 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.81 derived: net income ÷ weighted average shares · filed 2023-05-15 | -$0.86 derived: net income ÷ weighted average shares · filed 2023-05-15 | ||||
| 2021-12-31 | -$0.38 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.63 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.68 derived: net income ÷ weighted average shares · filed 2023-03-31 | -$0.79 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | -$0.26 10-Q · filed 2022-11-14 | -$0.30 derived: net income ÷ weighted average shares · filed 2022-11-14 | -$0.41 10-Q · filed 2022-11-14 | |||||
| 2021-06-30 | -$0.04 10-Q · filed 2022-08-11 | -$0.15 10-Q · filed 2022-08-11 | ||||||
| 2021-03-31 | -$0.11 10-Q · filed 2022-05-12 | |||||||
| 2020-03-31 | -$0.19 10-Q · filed 2020-05-11 | |||||||
| 2019-03-31 | $0.02 10-Q · filed 2020-05-11 | |||||||
| 2018-03-31 | -$0.49 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |